Surgical management for non-functional pancreatic neuroendocrine neoplasms with synchronous liver metastasis: A consensus from the Chinese Study Group for Neuroendocrine Tumors (CSNET)
- Authors:
- Kaizhou Jin
- Jin Xu
- Jie Chen
- Minhu Chen
- Rufu Chen
- Ye Chen
- Zhiyu Chen
- Bin Cheng
- Yihebali Chi
- Shi-Ting Feng
- Deliang Fu
- Baohua Hou
- Dan Huang
- Heguang Huang
- Qiang Huang
- Jie Li
- Ying Li
- Houjie Liang
- Rong Lin
- An'an Liu
- Jixi Liu
- Xubao Liu
- Ming Lu
- Jie Luo
- Gang Mai
- Quanxing Ni
- Meng Qiu
- Chenghao Shao
- Baiyong Shen
- Weiqi Sheng
- Jian Sun
- Chunlu Tan
- Huangying Tan
- Qiyun Tang
- Yingmei Tang
- Xiaodong Tian
- Danian Tong
- Xiaohong Wang
- Jian Wang
- Jie Wang
- Wei Wang
- Yu Wang
- Zheng Wu
- Ling Xue
- Qiang Yan
- Ning Yang
- Yinmo Yang
- Zhiying Yang
- Xiaoyi Yin
- Chunhui Yuan
- Shan Zeng
- Renchao Zhang
- Xianjun Yu
-
Affiliations: Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, P.R. China, Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P.R. China, Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P.R. China, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P.R. China, Department of Medical Oncology, Shanghai Cancer Center, Fudan University, Shanghai, P.R. China, Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P.R. China, Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, P.R. China, Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P.R. China, Department of Pancreatic Surgery, Huashan Hospital, Fudan University, Shanghai, P.R. China, Department of General Surgery, Guangdong General Hospital, Guangzhou, Guangdong, P.R. China, Department of Pathology, Shanghai Cancer Center, Fudan University, Shanghai, P.R. China, Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, P.R. China, Department of General Surgery, Anhui Provincial Hospital, Hefei, Anhui, P.R. China, Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Beijing Cancer Hospital, Beijing, P.R. China, Department of Radiology, Peking University Cancer Hospital, Beijing, P.R. China, Department of Oncology, Southwest Hospital, Third Military Medical University, Chongqing, P.R. China, Department of Gastroenterology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P.R. China, Department of General Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, P.R. China, Department of Gastroenterology, China-Japan Friendship Hospital, Beijing, P.R. China, Department of Hepatobiliopancreatic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China, Department of Pathology, China-Japan Friendship Hospital, Beijing, P.R. China, Department of Hepatobiliopancreatic Surgery, The People's Hospital of Deyang, Chengdu, Sichuan, P.R. China, Department of Abdominal Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China, Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China, Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing, P.R. China, Department of Gastroenterology, Jiangsu People's Hospital, Nanjing, Jiangsu, P.R. China, Department of Gastroenterology, The Second Affliated Hospital of Kunming Medical University, Yunnan Research Center for Liver Diseases, Kunming, Yunnan, P.R. China, Department of General Surgery, Peking University First Hospital, Beijing, P.R. China, Department of Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, P.R. China, Department of Radiology, Shanghai Cancer Center, Fudan University, Shanghai, P.R. China, Department of Biliary-Pancreatic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China, Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, P.R. China, Department of Surgery, Huadong Hospital, Fudan University, Shanghai, P.R. China, Department of Gastric and Pancreatic Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, P.R. China, Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou Guangdong, P.R. China, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, P.R. China, Department of Pathology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, P.R. China, Department of Hepatobiliopancreatic Surgery, Huzhou Central Hospital, Huzhou, Zhejiang, P.R. China, Hepatobiliary Surgery Department V, Eastern Hepatobiliary Surgery Hospital, Shanghai, P.R. China, Department of Hepatobiliary Surgery, China-Japan Friendship Hospital, Beijing, P.R. China, Department of Biliary-Pancreatic Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, P.R. China, Department of General Surgery, Peking University Third Hospital, Beijing, P.R. China, Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, P.R. China, Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University; Shanghai, P.R. China - Published online on: September 27, 2016 https://doi.org/10.3892/ijo.2016.3711
- Pages: 1991-2000
This article is mentioned in:
Abstract
 |
|
Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, et al: One hundred years after ‘carcinoid’: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 26:3063–3072. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Tsai HJ, Wu CC, Tsai CR, Lin SF, Chen LT and Chang JS: The epidemiology of neuroendocrine tumors in Taiwan: A nationwide cancer registry-based study. PLoS One. 8:e624872013. View Article : Google Scholar | |
|
Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, et al: Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 9:61–72. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Halfdanarson TR, Rabe KG, Rubin J and Petersen GM: Pancreatic neuroendocrine tumors (PNETs): Incidence, prognosis and recent trend toward improved survival. Ann Oncol. 19:1727–1733. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Chamberlain RS, Canes D, Brown KT, Saltz L, Jarnagin W, Fong Y and Blumgart LH: Hepatic neuroendocrine metastases: Does intervention alter outcomes? J Am Coll Surg. 190:432–445. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Modlin IM, Lye KD and Kidd M: A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 97:934–959. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Oberg K and Eriksson B: Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol. 19:753–781. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Kulke MH, Shah MH, Benson AB III, Bergsland E, Berlin JD, Blaszkowsky LS, Emerson L, Engstrom PF, Fanta P, Giordano T, et al; National Comprehensive Cancer Network. Neuroendocrine tumors, version 1.2015. J Natl Compr Cancer Netw. 13:78–108. 2015. | |
|
Nave H, Mössinger E, Feist H, Lang H and Raab H: Surgery as primary treatment in patients with liver metastases from carcinoid tumors: A retrospective, unicentric study over 13 years. Surgery. 129:170–175. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Capurso G, Bettini R, Rinzivillo M, Boninsegna L, Delle Fave G and Falconi M: Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable meta-static liver disease: A systematic review. Neuroendocrinology. 93:223–229. 2011. View Article : Google Scholar | |
|
Frilling A, Li J, Malamutmann E, Schmid KW, Bockisch A and Broelsch CE: Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease. Br J Surg. 96:175–184. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Frilling A, Modlin IM, Kidd M, Russell C, Breitenstein S, Salem R, Kwekkeboom D, Lau WY, Klersy C, Vilgrain V, et al; Working Group on Neuroendocrine Liver Metastases. Recommendations for management of patients with neuroendocrine liver metastases. Lancet Oncol. 15:e8–e21. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Martin-Perez E, Capdevila J, Castellano D, Jimenez-Fonseca P, Salazar R, Beguiristain-Gomez A, Alonso-Orduña V, Martinez Del Prado P, Villabona-Artero C, Diaz-Perez JA, et al: The Large Experience of the Spanish National Tumor Registry (RGETNE): Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE). Neuroendocrinology. 98:156–168. 2013. View Article : Google Scholar | |
|
Rindi G, Arnold R and Bosman FT: Nomenclature and classification of neuroendocrine neoplasms of the digestive system. WHO Classification of Tumours of the Digestive System. Bosman FT, Carneiro F, Hruban RH and Theise ND: IARC, Press; Lyon: 2010 | |
|
Tang LH, Untch BR, Reidy DL, O'Reilly E, Dhall D, Jih L, Basturk O, Allen PJ and Klimstra DS: Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: A pathway distinct from poorly differentiated neuroendocrine carcinomas. Clin Cancer Res. 22:1011–1017. 2016. View Article : Google Scholar | |
|
Garcia-Carbonero R, Sorbye H, Baudin E, Raymond E, Wiedenmann B, Niederle B, Sedlackova E, Toumpanakis C, Anlauf M, Cwikla JB, et al; Vienna Consensus Conference participants. ENETS Consensus guidelines for high-grade gastroenteropancreatic neuroendocrine Tumors and neuroendocrine carcinomas. Neuroendocrinology. 103:186–194. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Goldin SB, Bradner MW, Zervos EE and Rosemurgy AS II : Assessment of pancreatic neoplasms: Review of biopsy techniques. J Gastrointest Surg. 11:783–790. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Rösch T, Lightdale CJ, Botet JF, Boyce GA, Sivak MV Jr, Yasuda K, Heyder N, Palazzo L, Dancygier H, Schusdziarra V, et al: Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med. 326:1721–1726. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Chang KJ, Albers CG, Erickson RA, Butler JA, Wuerker RB and Lin F: Endoscopic ultrasound-guided fine needle aspiration of pancreatic carcinoma. Am J Gastroenterol. 89:263–266. 1994.PubMed/NCBI | |
|
Chatzipantelis P, Salla C, Konstantinou P, Karoumpalis I, Sakellariou S and Doumani I: Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: A study of 48 cases. Cancer. 114:255–262. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Jani N, Khalid A, Kaushik N, Brody D, Bauer K, Schoedel K, Ohori NP, Moser AJ, Lee K and McGrath K: EUS-guided FNA diagnosis of pancreatic endocrine tumors: New trends identified. Gastrointest Endosc. 67:44–50. 2008. View Article : Google Scholar | |
|
Voss M, Hammel P, Molas G, Palazzo L, Dancour A, O'Toole D, Terris B, Degott C, Bernades P and Ruszniewski P: Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut. 46:244–249. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Fujimori N, Osoegawa T, Lee L, Tachibana Y, Aso A, Kubo H, Kawabe K, Igarashi H, Nakamura K, Oda Y, et al: Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors. Scand J Gastroenterol. 51:245–252. 2016. View Article : Google Scholar | |
|
Hasegawa T, Yamao K, Hijioka S, Bhatia V, Mizuno N, Hara K, Imaoka H, Niwa Y, Tajika M, Kondo S, et al: Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy. 46:32–38. 2014. | |
|
Tyng CJ, Almeida MF, Barbosa PN, Bitencourt AG, Berg JA, Maciel MS, Coimbra FJ, Schiavon LH, Begnami MD, Guimarães MD, et al: Computed tomography-guided percutaneous core needle biopsy in pancreatic tumor diagnosis. World J Gastroenterol. 21:3579–3586. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yang RY, Ng D, Jaskolka JD, Rogalla P and Sreeharsha B: Evaluation of percutaneous ultrasound-guided biopsies of solid mass lesions of the pancreas: A center's 10-year experience. Clin Imaging. 39:62–65. 2015. View Article : Google Scholar | |
|
Yu YP, Jiang HT, Yao Z, Xia QR, Hong FM, Zeng H and Li S: Feasibility and safety of CT-guided percutaneous needle biopsy and subsequent iodine-125 seed interstitial implantation for pancreatic cancer. Zhonghua Zhong Liu Za Zhi. 35:608–612. 2013.(In Chinese). PubMed/NCBI | |
|
Karlson BM, Forsman CA, Wilander E, Skogseid B, Lindgren PG, Jacobson G and Rastad J: Efficiency of percutaneous core biopsy in pancreatic tumor diagnosis. Surgery. 120:75–79. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Dhall D, Mertens R, Bresee C, Parakh R, Wang HL, Li M, Dhall G, Colquhoun SD, Ines D, Chung F, et al: Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors. Hum Pathol. 43:489–495. 2012. View Article : Google Scholar | |
|
Couvelard A, Deschamps L, Ravaud P, Baron G, Sauvanet A, Hentic O, Colnot N, Paradis V, Belghiti J, Bedossa P, et al: Heterogeneity of tumor prognostic markers: A reproducibility study applied to liver metastases of pancreatic endocrine tumors. Mod Pathol. 22:273–281. 2009. View Article : Google Scholar | |
|
Zen Y and Heaton N: Elevated Ki-67 labeling index in ‘synchronous liver metastases’ of well differentiated enteropancreatic neuroendocrine tumor. Pathol Int. 63:532–538. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Singh S, Hallet J, Rowsell C and Law CH: Variability of Ki67 labeling index in multiple neuroendocrine tumors specimens over the course of the disease. Eur J Surg Oncol. 40:1517–1522. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Grillo F, Albertelli M, Brisigotti MP, Borra T, Boschetti M, Fiocca R, Ferone D and Mastracci L: Grade increases in gastro-Enteropancreatic neuroendocrine tumor metastases compared to the primary tumor. Neuroendocrinology. 103:452–459. 2015. View Article : Google Scholar | |
|
Singh S, Dey C, Kennecke H, Kocha W, Maroun J, Metrakos P, Mukhtar T, Pasieka J, Rayson D, Rowsell C, et al: Consensus recommendations for the diagnosis and management of pancreatic neuroendocrine tumors: Guidelines from a Canadian National Expert group. Ann Surg Oncol. 22:2685–2699. 2015. View Article : Google Scholar | |
|
Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'Connor JM, Salazar R, Taal BG, Vullierme MP and O'Toole D; Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: Well-differentiated pancreatic non-functioning tumors. Neuroendocrinology. 95:120–134. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kulke MH, Anthony LB, Bushnell DL, de Herder WW, Goldsmith SJ, Klimstra DS, Marx SJ, Pasieka JL, Pommier RF, Yao JC, et al: North American Neuroendocrine Tumor Society (NANETS): NANETS treatment guidelines: Well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas. 39:735–752. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Öberg K, Knigge U, Kwekkeboom D and Perren A; ESMO Guidelines Working Group. Neuroendocrine gastro-enteropancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 23(Suppl 7): vii124–vii130. 2012. | |
|
Fischer L, Kleeff J, Esposito I, Hinz U, Zimmermann A, Friess H and Büchler MW: Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg. 95:627–635. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Pavel M, Baudin E, Couvelard A, Krenning E, Öberg K, Steinmüller T, Anlauf M, Wiedenmann B and Salazar R; Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 95:157–176. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kunz PL, Reidy-Lagunes D, Anthony LB, Bertino EM, Brendtro K, Chan JA, Chen H, Jensen RT, Kim MK, Klimstra DS, et al; North American Neuroendocrine Tumor Society. Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas. 42:557–577. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Manual. Springer; New York, NY: 2010 | |
|
Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, et al; all other Frascati Consensus Conference participants; European Neuroendocrine Tumor Society (ENETS). TNM staging of foregut (neuro)endocrine tumors: A consensus proposal including a grading system. Virchows Arch. 449:395–401. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Norton JA, Warren RS, Kelly MG, Zuraek MB and Jensen RT: Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery. 134:1057–1063; discussion 1063–1065. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Elias D, Lasser P, Ducreux M, Duvillard P, Ouellet JF, Dromain C, Schlumberger M, Pocard M, Boige V, Miquel C, et al: Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: A 15-year single center prospective study. Surgery. 133:375–382. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Watzka FM, Fottner C, Miederer M, Schad A, Weber MM, Otto G, Lang H and Musholt TJ: Surgical therapy of neuroendocrine neoplasm with hepatic metastasis: Patient selection and prognosis. Langenbecks Arch Surg. 400:349–358. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Mayo SC, de Jong MC, Pulitano C, Clary BM, Reddy SK, Gamblin TC, Celinksi SA, Kooby DA, Staley CA, Stokes JB, et al: Surgical management of hepatic neuroendocrine tumor metastasis: Results from an international multi-institutional analysis. Ann Surg Oncol. 17:3129–3136. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Steinmüller T, Kianmanesh R, Falconi M, Scarpa A, Taal B, Kwekkeboom DJ, Lopes JM, Perren A, Nikou G, Yao J, et al; Frascati Consensus Conference participants. Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: Foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 87:47–62. 2008. View Article : Google Scholar | |
|
Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM and Que FG: Surgical treatment of neuroendocrine metastases to the liver: A plea for resection to increase survival. J Am Coll Surg. 197:29–37. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Kandil E, Noureldine SI, Koffron A, Yao L, Saggi B and Buell JF: Outcomes of laparoscopic and open resection for neuroendocrine liver metastases. Surgery. 152:1225–1231. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Dousset B, Saint-Marc O, Pitre J, Soubrane O, Houssin D and Chapuis Y: Metastatic endocrine tumors: Medical treatment, surgical resection, or liver transplantation. World J Surg. 20:908–914; discussion 914–915. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Kimura W, Tezuka K and Hirai I: Surgical management of pancreatic neuroendocrine tumors. Surg Today. 41:1332–1343. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hanazaki K, Sakurai A, Munekage M, Ichikawa K, Namikawa T, Okabayashi T and Imamura M: Surgery for a gastroenteropancreatic neuroendocrine tumor (GEPNET) in multiple endocrine neoplasia type 1. Surg Today. 43:229–236. 2013. View Article : Google Scholar | |
|
Bloomston M, Muscarella P, Shah MH, Frankel WL, Al-Saif O, Martin EW and Ellison EC: Cytoreduction results in high perioperative mortality and decreased survival in patients undergoing pancreatectomy for neuroendocrine tumors of the pancreas. J Gastrointest Surg. 10:1361–1370. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Pavel M, O'Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, Krenning E, Knigge U, Salazar R, Pape UF, et al; Vienna Consensus Conference participants. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 103:172–185. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Maxwell JE, Sherman SK, O'Dorisio TM, Bellizzi AM and Howe JR: Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy? Surgery. 159:320–333. 2016. View Article : Google Scholar | |
|
Gaujoux S, Gonen M, Tang L, Klimstra D, Brennan MF, D'Angelica M, Dematteo R, Allen PJ, Jarnagin W and Fong Y: Synchronous resection of primary and liver metastases for neuroendocrine tumors. Ann Surg Oncol. 19:4270–4277. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zerbi A, Capitanio V, Boninsegna L, Delle Fave G, Pasquali C, Rindi G, Campana D and Falconi M; AISP-Network Study Group. Treatment of malignant pancreatic neuroendocrine neoplasms: Middle-term (2-year) outcomes of a prospective observational multicentre study. HPB Oxf. 15:935–943. 2013. View Article : Google Scholar | |
|
Cusati D, Zhang L, Harmsen WS, Hu A, Farnell MB, Nagorney DM, Donohue JH, Que FG, Reid-Lombardo KM and Kendrick ML: Metastatic nonfunctioning pancreatic neuroendocrine carcinoma to liver: Surgical treatment and outcomes. J Am Coll Surg. 215:117–124; discussion 124–125. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mayo SC, de Jong MC, Bloomston M, Pulitano C, Clary BM, Reddy SK, Clark Gamblin T, Celinski SA, Kooby DA, Staley CA, et al: Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: A multicenter international analysis. Ann Surg Oncol. 18:3657–3665. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bettini R, Mantovani W, Boninsegna L, Crippa S, Capelli P, Bassi C, Scarpa A, Pederzoli P and Falconi M: Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. Dig Liver Dis. 41:49–55. 2009. View Article : Google Scholar | |
|
Sarmiento JM and Que FG: Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am. 12:231–242. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Chambers AJ, Pasieka JL, Dixon E and Rorstad O: The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors. Surgery. 144:645–651; discussion 651–653. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG, Hawkins IF and Vauthey JN: Preoperative portal vein embolization for extended hepatectomy. Ann Surg. 237:686–691; discussion 691–693. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Yigitler C, Farges O, Kianmanesh R, Regimbeau JM, Abdalla EK and Belghiti J: The small remnant liver after major liver resection: How common and how relevant? Liver Transpl. 9:S18–S25. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Goessmann H, Lang SA, Fichtner-Feigl S, Scherer MN, Schlitt HJ, Stroszczynski C, Schreyer AG and Schnitzbauer AA: Biliodigestive anastomosis: Indications, complications and interdisciplinary management. Chirurg. 83:1097–1108. 2012.(In German). View Article : Google Scholar : PubMed/NCBI | |
|
Kianmanesh R, Sauvanet A, Hentic O, Couvelard A, Lévy P, Vilgrain V, Ruszniewski P and Belghiti J: Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: A safe approach for radical resection. Ann Surg. 247:659–665. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Hörbelt R, et al: Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 255:405–414. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Glazer ES, Tseng JF, Al-Refaie W, Solorzano CC, Liu P, Willborn KA, Abdalla EK, Vauthey JN and Curley SA: Long-term survival after surgical management of neuroendocrine hepatic metastases. HPB Oxf. 12:427–433. 2010. View Article : Google Scholar | |
|
Taner T, Atwell TD, Zhang L, Oberg TN, Harmsen WS, Slettedahl SW, Kendrick ML, Nagorney DM and Que FG: Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection. HPB Oxf. 15:190–195. 2013. View Article : Google Scholar | |
|
Frilling A and Clift AK: Therapeutic strategies for neuroendocrine liver metastases. Cancer. 121:1172–1186. 2015. View Article : Google Scholar | |
|
Frilling A, Sotiropoulos GC, Li J, Kornasiewicz O and Plöckinger U: Multimodal management of neuroendocrine liver metastases. HPB Oxf. 12:361–379. 2010. View Article : Google Scholar | |
|
Jagannath P, Chhabra D, Shrikhande S and Shah R: Surgical treatment of liver metastases in neuroendocrine neoplasms. Int J Hepatol. 2012:7826722012. View Article : Google Scholar : PubMed/NCBI | |
|
Bertani E, Fazio N, Botteri E, Chiappa A, Falconi M, Grana C, Bodei L, Papis D, Spada F, Bazolli B, et al: Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: Possible indications for a multimodal approach. Surgery. 155:607–614. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Nguyen SQ, Angel LP, Divino CM, Schluender S and Warner RR: Surgery in malignant pancreatic neuroendocrine tumors. J Surg Oncol. 96:397–403. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Basturk O, Yang Z, Tang LH, Hruban RH, Adsay V, McCall CM, Krasinskas AM, Jang KT, Frankel WL, Balci S, et al: The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms. Am J Surg Pathol. 39:683–690. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Heetfeld M, Chougnet CN, Olsen IH, Rinke A, Borbath I, Crespo G, Barriuso J, Pavel M, O'Toole D and Walter T; other Knowledge Network members. Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer. 22:657–664. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ilett EE, Langer SW, Olsen IH, Federspiel B, Kjær A and Knigge U: Neuroendocrine carcinomas of the gastroenteropancreatic system: A comprehensive review. Diagnostics Basel. 5:119–176. 2015. View Article : Google Scholar | |
|
Panzuto F, Boninsegna L, Fazio N, Campana D, Pia Brizzi M, Capurso G, Scarpa A, De Braud F, Dogliotti L, Tomassetti P, et al: Metastatic and locally advanced pancreatic endocrine carcinomas: Analysis of factors associated with disease progression. J Clin Oncol. 29:2372–2377. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Cho MY, Kim JM, Sohn JH, Kim MJ, Kim KM, Kim WH, Kim H, Kook MC, Park DY, Lee JH, et al; Gastrointestinal Pathology Study Group of Korean Society of Pathologists. Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000–2009 Multicenter Study. Cancer Res Treat. 44:157–165. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Strosberg JR, Coppola D, Klimstra DS, Phan AT, Kulke MH, Wiseman GA and Kvols LK; North American Neuroendocrine Tumor Society (NANETS). The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas. 39:799–800. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Nilsson O, Van Cutsem E, Delle Fave G, Yao JC, Pavel ME, McNicol AM, Sevilla Garcia MI, Knapp WH, Keleştimur F, Sauvanet A, et al; Frascati Consensus Conference; European Neuroendocrine Tumor Society. Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic). Neuroendocrinology. 84:212–215. 2006. View Article : Google Scholar | |
|
Akerström G: Management of carcinoid tumors of the stomach, duodenum, and pancreas. World J Surg. 20:173–182. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Kölby L, Nilsson O and Ahlman H: Gastroduodenal endocrine tumours. Scand J Surg. 93:317–323. 2004. | |
|
Du S, Ni J, Weng L, Ma F, Li S, Wang W, Sang X, Lu X, Zhong S and Mao Y: Aggressive locoregional treatment improves the outcome of liver metastases from grade 3 gastroenteropancreatic neuroendocrine tumors. Medicine (Baltimore). 94:e14292015. View Article : Google Scholar | |
|
Haugvik SP, Janson ET, Österlund P, Langer SW, Falk RS, Labori KJ, Vestermark LW, Gr⊘nbæk H, Gladhaug IP and Sorbye H: Surgical treatment as a principle for patients with high-grade pancreatic neuroendocrine carcinoma: A Nordic multicenter comparative study. Ann Surg Oncol. 23:1721–1728. 2016. View Article : Google Scholar | |
|
Schweizer RT, Alsina AE, Rosson R and Bartus SA: Liver transplantation for metastatic neuroendocrine tumors. Transplant Proc. 25:19731993.PubMed/NCBI | |
|
Lehnert T: Liver transplantation for metastatic neuroendocrine carcinoma: An analysis of 103 patients. Transplantation. 66:1307–1312. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Olausson M, Friman S, Herlenius G, Cahlin C, Nilsson O, Jansson S, Wängberg B and Ahlman H: Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors. Liver Transpl. 13:327–333. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Frilling A, Malago M, Weber F, Paul A, Nadalin S, Sotiropoulos GC, Cicinnati V, Beckebaum S, Bockisch A, Mueller-Brand J, et al: Liver transplantation for patients with metastatic endocrine tumors: Single-center experience with 15 patients. Liver Transpl. 12:1089–1096. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
van Vilsteren FG, Baskin-Bey ES, Nagorney DM, Sanderson SO, Kremers WK, Rosen CB, Gores GJ and Hobday TJ: Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival. Liver Transpl. 12:448–456. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Rosenau J, Bahr MJ, von Wasielewski R, Mengel M, Schmidt HH, Nashan B, Lang H, Klempnauer J, Manns MP and Boeker KH: Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation. 73:386–394. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Le Treut YP, Grégoire E, Klempnauer J, Belghiti J, Jouve E, Lerut J, Castaing D, Soubrane O, Boillot O, Mantion G, et al; For ELITA. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: A 213-case European liver transplant registry study. Ann Surg. 257:807–815. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Mazzaferro V, Pulvirenti A and Coppa J: Neuroendocrine tumors metastatic to the liver: How to select patients for liver transplantation? J Hepatol. 47:460–466. 2007. View Article : Google Scholar : PubMed/NCBI |
